NO883375L - Fremgangsmaate til fremstilling av farmasoeytisk kombinasjonspreparat samt dets anvendelse. - Google Patents

Fremgangsmaate til fremstilling av farmasoeytisk kombinasjonspreparat samt dets anvendelse.

Info

Publication number
NO883375L
NO883375L NO88883375A NO883375A NO883375L NO 883375 L NO883375 L NO 883375L NO 88883375 A NO88883375 A NO 88883375A NO 883375 A NO883375 A NO 883375A NO 883375 L NO883375 L NO 883375L
Authority
NO
Norway
Prior art keywords
preparation
procedure
pharmaceutical combination
combination preparation
retroviruses
Prior art date
Application number
NO88883375A
Other languages
English (en)
Other versions
NO883375D0 (no
NO174834B (no
NO174834C (no
Inventor
Elmar Shrinner
Irvin Winkler
Christoph Meichsner
Matthias Helsberg
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO883375D0 publication Critical patent/NO883375D0/no
Publication of NO883375L publication Critical patent/NO883375L/no
Publication of NO174834B publication Critical patent/NO174834B/no
Publication of NO174834C publication Critical patent/NO174834C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO883375A 1987-08-01 1988-07-29 Fremgangsmåte til fremstilling av farmasöytisk kombinasjonspreparat NO174834C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3725554A DE3725554A1 (de) 1987-08-01 1987-08-01 Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung

Publications (4)

Publication Number Publication Date
NO883375D0 NO883375D0 (no) 1988-07-29
NO883375L true NO883375L (no) 1989-02-02
NO174834B NO174834B (no) 1994-04-11
NO174834C NO174834C (no) 1994-07-20

Family

ID=6332870

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883375A NO174834C (no) 1987-08-01 1988-07-29 Fremgangsmåte til fremstilling av farmasöytisk kombinasjonspreparat

Country Status (18)

Country Link
US (1) US5055457A (no)
EP (1) EP0305743B1 (no)
JP (1) JPS6450821A (no)
KR (1) KR890003383A (no)
CN (1) CN1031184A (no)
AT (1) ATE81980T1 (no)
AU (1) AU617115B2 (no)
CA (1) CA1328404C (no)
DE (2) DE3725554A1 (no)
DK (1) DK425288A (no)
ES (1) ES2052647T3 (no)
GR (1) GR3006992T3 (no)
HU (1) HU204999B (no)
IL (1) IL87287A0 (no)
NO (1) NO174834C (no)
NZ (1) NZ225611A (no)
PT (1) PT88150B (no)
ZA (1) ZA885577B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3842362A1 (de) * 1988-12-16 1990-06-28 Hoechst Ag Pharmazeutische kombinationspraeparate enthaltend nucleosid-derivate und pentosanpolysulfat, sowie deren herstellung und verwendung
US5272261A (en) * 1989-01-11 1993-12-21 Merrell Dow Pharmaceuticals Inc. Preparation of sulfated polysaccharide fractions
AU620218B2 (en) * 1989-02-10 1992-02-13 Taiho Pharmaceutical Co., Ltd. Anti-hiv drug
NZ234534A (en) * 1989-07-17 1994-12-22 Univ Birmingham Pyrimidine 4'-thionucleoside derivatives and their preparation; intermediates therefor
DE3928769A1 (de) * 1989-08-31 1991-03-14 Ulrich Dr Med Kuebler Verfahren und pharmazeutische mischung zur aufrechterhaltung und wiederherstellung des zinkgehaltes von retroviral infizierten zellen, sowie zur unterdrueckung und prophylaxe der transformierung von humanen b-lymphozyten durch eb-viren
DE4021066A1 (de) * 1990-07-03 1992-01-09 Hoechst Ag Langzeitprophylaxe gegen erkrankungen, die durch viren oder durch unkonventionelle viren verursacht werden
US5521163A (en) * 1990-07-13 1996-05-28 University Of Birmingham Antiviral pyrimidine nucleosides and methods for using same
US5514667A (en) * 1990-11-05 1996-05-07 Arthropharm Pty. Limited Method for topical treatment of herpes infections
EP0484785B1 (en) * 1990-11-07 1996-05-22 Hoechst-Roussel Pharmaceuticals Incorporated Use of xanthines for the preparation of a medicament effective for inhibiting the replication of human retroviruses
US5603963A (en) * 1994-07-28 1997-02-18 University Of Cincinnati Method for the treatment of retroviral diseases such as acquired immune deficiency syndrome utilizing (pseudo)halogen complexes of gold(1)
US5643892A (en) * 1995-06-07 1997-07-01 Baker Norton Pharmaceuticals, Inc. Method of treating chronic progressive vascular diseases
DE10063111A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Replikationsassay zur Auffindung antiviraler Substanzen
EP1718315A4 (en) * 2004-02-06 2008-08-13 Univ Monash HIGH-DOSE USE AND SHORT INTERVAL OF SULFATE POLYSACCHARIDES IN THE TREATMENT OF INFECTIONS
RU2468106C1 (ru) * 2011-05-31 2012-11-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Сплав на основе алюминия

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3175942A (en) * 1962-03-13 1965-03-30 Evans Medical Ltd Gastro-intestinal therapeutic
DE2335170C2 (de) * 1973-07-11 1989-07-20 Hoechst Ag, 6230 Frankfurt 1,3-Dialkyl-7-(hydroxyalkyl)-xanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2364373A1 (de) * 1973-12-22 1975-07-10 Hahn Carl Dr Gmbh Pharmazeutische und kosmetische praeparate zur aeusserlichen anwendung
DE3173289D1 (en) * 1980-06-21 1986-02-06 Beecham Wuelfing Gmbh & Co Kg Xanthine derivatives, pharmaceutical compositions containing them and a process for their preparation
US4533493A (en) * 1981-08-27 1985-08-06 Miles Laboratories, Inc. Theophylline immunogens, antibodies, labeled conjugates, and related derivatives
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
DE3640610A1 (de) * 1986-11-27 1988-06-09 Uhde Gmbh Verfahren und vorrichtung zum konditionieren von wasserhaltigem schuettgutmaterial
NZ222695A (en) * 1986-11-29 1990-03-27 Ueno Seiyaku Oyo Kenkyujo Kk Synergistic antiviral compositions
AU609234B2 (en) * 1987-12-21 1991-04-26 Forest Laboratories, Inc. Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system

Also Published As

Publication number Publication date
GR3006992T3 (no) 1993-06-30
DK425288D0 (da) 1988-07-29
EP0305743A3 (en) 1990-04-04
DE3875674D1 (de) 1992-12-10
EP0305743B1 (de) 1992-11-04
NO883375D0 (no) 1988-07-29
NZ225611A (en) 1991-09-25
NO174834B (no) 1994-04-11
AU617115B2 (en) 1991-11-21
JPS6450821A (en) 1989-02-27
PT88150A (pt) 1989-06-30
IL87287A0 (en) 1989-01-31
KR890003383A (ko) 1989-04-14
AU2017988A (en) 1989-02-02
CN1031184A (zh) 1989-02-22
DE3725554A1 (de) 1989-02-09
HU204999B (en) 1992-03-30
HUT52957A (en) 1990-09-28
ZA885577B (en) 1989-04-26
NO174834C (no) 1994-07-20
PT88150B (pt) 1995-03-01
DK425288A (da) 1989-02-02
EP0305743A2 (de) 1989-03-08
ATE81980T1 (de) 1992-11-15
US5055457A (en) 1991-10-08
CA1328404C (en) 1994-04-12
ES2052647T3 (es) 1994-07-16

Similar Documents

Publication Publication Date Title
NO883375L (no) Fremgangsmaate til fremstilling av farmasoeytisk kombinasjonspreparat samt dets anvendelse.
NL194728B (nl) Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan.
NO166184C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n9-cyklopentyl-substituerte adeninderivater.
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO870240L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
NO165843C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-6 -substituerte adenosiner.
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
ATE69953T1 (de) Verwendung von polysulfatierten heparinen.
NO880473L (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel.
NO883833L (no) Fremgangsmaate for fremstilling av isoxazol-betacarbolinderivater.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO167980C (no) Analogifremgangsmaate for fremstilling av tienoimidazol-derivater.
NO894949D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzopyranylpyrrolinonderivater.
NO865139D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperazin-1,4-naftalendion-derivater.
NO881775L (no) Kondenserte heteroalkylen-kinolinaminer, en fremgangsmaateog mellomprodukter for deres fremstilling samt anvendelseav forbindelsene som medikamenter.
NO167144C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv imidazo (4,5-f) isokinolin-2-on.
NO890428L (no) Fremgangsmaate for fremstilling av sulfaterte alkanol- eller alkylfenol-oksetylater med redusert innhold av 1,4-dioksan.
NO882599L (no) Profylaktisk middel for kontroll av veneriske sykdommer.
DK73888A (da) Parenteralt indgivelige blodprodukter, fremgangsmaade til fremstilling heraf samt deres anvendelse
NO165235C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 2-substituerte-3,4-dihydroksyfenyletylamino-derivater.
NO872347D0 (no) Asfaltmasse, fremgangsmaate for fremstilling av en slik, samt anvendelse av asfaltmassen.
NO871195L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv 1-cyklopropyl-6-fluor-1,4-dihydro-4-okso-7-piperazino kinolin-3-karboksylsyre.
NO160519C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive s- adenosylmethioninacylderivater.
NO159529C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 3-substituerte tetrahydro-1,2,4,-triaziner.
NO164532C (no) Analogifremgangsmaate for fremstilling av acetyldikarnitindiklorid.